Clinical Operations in Oncology Trials 2021

Biography:

Session Details: What does Covid-19 exposure mean for cancer patient health and clinical trials? 24-06-2021, 3:55 pm View In Agenda

Biography: Narayan has and ten (10)+ years of award-winning and progressive experience delivering the highest standards of clinical data management at Bayer and Bristol Myers Squibb (BMS). Bayer Gold Award 2017, Bronze Award 2016, and Pinnacle Award 2015; BMS Performance Award. In-depth knowledge of all aspects of clinical data management, reporting, reconciliation, study reviews, and standards development that drive pharmaceutical businesses forward. 

Session Details: How Data Managers Should Review the Data and Oncology Data Primarily 24-06-2021, 2:15 pm View In Agenda

Biography:

Session Details: The Role of the ‘Virtual’ Patient In Oncology Trials 24-06-2021, 10:00 am View In Agenda

Biography:

Session Details: View In Agenda

Biography:

Session Details: Keynote: Analyzing the Affect of COVID-19 Disease on Oncology Clinical Operations and How the Industry Responded 24-06-2021, 2:45 pm View In Agenda

Biography:

Session Details: Patient Centricity Considerations and Challenges In Oncology Based Trials 24-06-2021, 3:55 pm View In Agenda

Biography: Bonnie Bain, PhD, is the Global Head and EVP of Healthcare Operations and Strategy. Bonnie has over 20 years’ experience in the healthcare sector and a proven track record of developing innovative solutions on both the client and agency sides of the business. Bonnie was GlobalData Healthcare’s first Western analyst, and under her leadership, the company launched a number of premium syndicated reports, analytical tools, and databases in the pharmaceuticals and medical devices space. Prior to GlobalData, Bonnie was Vice President and Global Research & Analysis Director for Informa’s Pharma Division, which includes Datamonitor Healthcare, Scrip Group, and Business Insight. Bonnie also worked for several years at Decision Resources as an Analyst and Project Manager. On the client side of the industry, Bonnie worked for several years as a Senior Manager in Marketing Strategy and Analytics at Boston Scientific, where her work contributed to the successful commercialization of the first ever Access and Visualization Platform at the company. Bonnie has a PhD in Biochemistry and Molecular Biology from Purdue University and completed a Post-Doctoral Fellowship in Molecular Pharmacology at the University Of Miami School Of Medicine. She also has a graduate certificate in Applied Management Principles from Purdue University Krannert School of Management.

Session Details: Embracing Disruption in Pharma – is COVID-19 a Catalyst for Lasting Change? 24-06-2021, 4:55 pm View In Agenda

Biography:

Session Details: Are digital tools and social media the future of patient recruitment and engagement? 24-06-2021, 2:15 pm View In Agenda

Biography:

Session Details: View In Agenda

Biography: Dr. Patt is co-founder and principal in RadMD. He has a broad prior experience in medical imaging: this includes research and development of contrast agents: design and manage site and central reviews and trained reviewers for over 300 oncology trials; and has expertise in cardiovascular device, infectious disease, and pulmonary fibrosis trials. He has performed blinded reads and adjudications in a variety of trial types. He has held positions as both an academic and private practice radiologist. After his fellowship at Georgetown University and the National Institutes of Health (NIH), he served as Chief of Body MRI, then Director of MRI, at Georgetown University Medical Center, where he was both an investigator and blinded reader in numerous pharmaceutical and medical device clinical trials. He subsequently joined Berlex Labs as Associate Director, followed by Director of Medical Imaging Clinical Development. where he managed an experienced team in all phases of clinical development of radiological contrast agents. Dr. Patt also served as Medical Director for HealthHelp, a radiology management services organization. He founded Foresight Consulting, working with pharmaceutical and medical device companies on the utilization of medical imaging into clinical development programs. He has numerous publications, has served on an NCI Advisory Panel, is a reviewer for major radiology journals, and has been an invited lecturer across the US and Europe on the use of medical imaging in clinical trials.

Session Details: How to manage 3 critical imaging issues that can sink your trial 24-06-2021, 3:25 pm View In Agenda

Biography: Julie Martin - CEO & co-Owner joined Scimega 9 years ago. Having worked for 2 other CROs before, her passion for Scimega’s business and team stems from knowing its expert oncology clinical development services add distinct value to industry stakeholders at a time when it’s needed most. As CEO, Julie’s vision is to secure the company’s long-term success by leveraging her in-depth industry expertise & business acumen. She equates that success with setting a clear vision for the organization’s continued sense of purpose. Her leadership & collaboration with the managing Board of Directors combined ensure the business excellence upon which Scimega has built its reputation. Julie plays a vital role in promoting Scimega’s expertise and showcasing Canada’s attributes as a formidable partner in global oncology drug development.

Session Details: Risk Mitigation for Oncology Clinical Trials 24-06-2021, 10:30 am View In Agenda

Biography:

Session Details: Using A Clinical Trial Matching Solution to Streamline Patient Treatment Matching & Improve Clinical Trial Accrual Rates 24-06-2021, 1:45 pm View In Agenda

Biography:

Megan brings nearly 23 years of industry experience across a broad range of therapeutic areas, including oncology, infectious disease, pain and respiratory with a focus on project management and clinical operations at both pharma and CROs.  She has experience with several types of agents with a specific interest in advancing cellular immunotherapeutics.  Megan recently presented at the ISCT Commercialization Series on start-up considerations for global expansion of cell therapy trials and previously presented a webinar entitled ‘Operational Excellence in Immuno-Oncology Clinical Trials’.  As a member of Precision’s Adoptive Cell Therapy working group, she works with scientific, medical and clinical operations experts to stay abreast of recent developments in this evolving space as well as assist in the standardization of forms, templates and trainings to promote consistency in execution of these trials at Precision.

Session Details: Considerations for Maximizing Clinical Trial Enrolment in an Endemic Era 24-06-2021, 12:45 pm View In Agenda

Biography:

Session Details: Unified Platforms: How to Address the Complexity of Oncology Studies to Better Support Your Sites 24-06-2021, 3:25 pm View In Agenda

Biography: Quinn leads her team in navigating Axiom's clients throughout their entire project lifecycle based on their study needs, from Fusion eClinical Suite configuration to database lock and closeout activity. Quinn’s team is dedicated to executing well-planned processes to offer clients the best possible experience. Her passion lays with developing strategy, processes, and people as we continue to grow.

Session Details: Unified Platforms: How to Address the Complexity of Oncology Studies to Better Support Your Sites 24-06-2021, 3:25 pm View In Agenda

Biography:

Session Details: View In Agenda

Biography: Dr. Jouravleva has over 20 years of leadership experience in varying aspects of the life sciences industry and clinical research. She has supported clinical trials working with various pharmaceutical and biotech companies and contributed to approvals by various regulatory agencies, numerous pharmaceutical, diagnostic and device products. Dr. Jouravleva currently supports US Oncology Research, a clinical trial site management organization representing approximately 160 locations across the United States, as the Director of Research Operations overseeing Regulatory Affairs, IRB and the Complementary CRO services groups. She holds Master of Science and Ph.D. degrees in Biology and focused her thesis on genetics of pathogenesis in Vibrio cholerae.

Session Details: Why US Oncology Research Trusts eConsent: How it Helps, Implementation Best Practices, and Lessons Learned 24-06-2021, 4:25 pm View In Agenda

Biography:

Session Details: Collaborate to Scale: The Path to Global Adoption of Decentralized Trials 24-06-2021, 11:00 am View In Agenda

Biography:

Session Details: Fireside Chat: Regulatory Considerations For Your Oncology Trial 24-06-2021, 1:45 pm View In Agenda